+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Age: 18Years +
All Genders
ID07225127

Comparing Bladder-Sparing Therapies and Surgery for Recurrent High-Grade Non-Muscle-Invasive Bladder Cancer A Patient and Caregiver Observational Study

Led by University of Washington · Updated on 2026-10-21

408

Participants Needed

6

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Bladder cancer is the most common urinary tract cancer and ranks as the 6th most common cancer in the US. Research in this area is underfunded compared to other cancers, leading to gaps in evidence that create uncertainty for patients and doctors. This study, called Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2 CISTO2, aims to address these gaps by comparing bladder-sparing therapies and bladder removal in patients with recurrent high-grade non-muscle-invasive bladder cancer NMIBC. The goal is to provide more personalized, patient-centered care by evaluating financial, clinical, and quality of life outcomes. The study follows patients who have chosen either radical cystectomy bladder removal surgery or bladder-sparing therapy BST, along with their caregivers. It observes and compares these groups without assigning treatments. The study collects data on financial toxicity, quality of life, anxiety, depression, and cancer progression over a period of up to 24 months after enrollment. Participants will complete surveys and questionnaires measuring financial distress, well-being, quality of life, urinary health, anxiety, and depression at 12 and 24 months after joining the study. Caregivers also report on their own quality of life and financial distress. Researchers will monitor patient survival and cancer outcomes for up to 12 months following diagnosis of recurrent high-grade NMIBC. The study provides insights into both patient and caregiver experiences during this time.

CONDITIONS

Brief Title

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Research Team

S

Sung Min Kim

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here